Year-end report 2019

Fourth quarter: Strengthened organic growth in Accessibility and strong cash flow; Patient Handling in US remained weakFourth quarter 2019 · Revenue amounted to MEUR 68.6 (69.2) · Organic growth was 1.2% · The gross margin was 40.6% (37.5) · Adjusted EBITA amounted to MEUR 4.8 (2.8), corresponding to a margin of 7.0% (4.1) · EBIT amounted to MEUR -7.1 (0.2), corresponding to a margin of -10.3% (0.3) · Net profit (including discontinued operations) amounted to MEUR -11.5 (0.9) · Earnings per share (including discontinued operations) before and after dilution amounted